With the Phase III trials looming, the results of Dr. Pridgen’s phase II clinical trials on his antiviral approach to fibromyalgia have been released.   His next step – finding a way through the “valley of death” where many drug possibilities go to die – and launch the Phase … Continue reading Through the “Valley of Death”: Pridgen, Fibromyalgia and the Looming Clinical Trials